Published in J Int AIDS Soc on June 18, 2013
Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States. J Acquir Immune Defic Syndr (2015) 1.12
HIV status disclosure to perinatally-infected adolescents in Zimbabwe: a qualitative study of adolescent and healthcare worker perspectives. PLoS One (2014) 1.06
Social protection: potential for improving HIV outcomes among adolescents. J Int AIDS Soc (2015) 0.86
Drug resistance in children at virological failure in a rural KwaZulu-Natal, South Africa, cohort. AIDS Res Ther (2014) 0.85
Addressing the socio-development needs of adolescents living with HIV/AIDS in Nigeria: a call for action. Afr J Reprod Health (2014) 0.83
Viral suppression in adolescents on antiretroviral treatment: review of the literature and critical appraisal of methodological challenges. Trop Med Int Health (2016) 0.83
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med (2016) 0.80
HIV treatment adherence measurement and reporting concordance in youth with perinatally acquired HIV infection and their caregivers. AIDS Patient Care STDS (2015) 0.80
Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study. PLoS One (2014) 0.79
Following young people with perinatal HIV infection from adolescence into adulthood: the protocol for PHACS AMP Up, a prospective cohort study. BMJ Open (2016) 0.79
Antiretroviral treatment in HIV-1 infected pediatric patients: focus on efavirenz. Pediatric Health Med Ther (2014) 0.79
Of mice and monkeys: can animal models be utilized to study neurological consequences of pediatric HIV-1 infection? ACS Chem Neurosci (2015) 0.79
'Everyone has a secret they keep close to their hearts': challenges faced by adolescents living with HIV infection at the Kenyan coast. BMC Public Health (2016) 0.77
Factors influencing social self-disclosure among adolescents living with HIV in Eastern Africa. AIDS Care (2015) 0.76
Factors influencing antiretroviral treatment suboptimal adherence among perinatally HIV-infected adolescents in Thailand. PLoS One (2017) 0.75
Perinatally infected adolescents living with human immunodeficiency virus (perinatally human immunodeficiency virus). World J Virol (2015) 0.75
Behaviorally and perinatally HIV-infected young women: targets for preconception counseling. AIDS Care (2016) 0.75
Getting to 90-90-90 in paediatric HIV: What is needed? J Int AIDS Soc (2015) 0.75
Hippocampal Neuronal Loss in Infant Macaques Orally Infected with Virulent Simian Immunodeficiency Virus (SIV). Brain Sci (2017) 0.75
Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth. JAMA Pediatr (2017) 0.75
The adherence-outcome relationship is not altered by diary-driven adjustments of microelectronic monitor data. Pharmacoepidemiol Drug Saf (2015) 0.75
Resilience and Life Expectations of Perinatally HIV-1 Infected Adolescents in France. Open AIDS J (2016) 0.75
HIV is always with me: men living with perinatally acquired HIV and planning their families. Open Access J Contracept (2017) 0.75
Meeting the WHO 90% target: antiretroviral treatment efficacy in Poland is associated with baseline clinical patient characteristics. J Int AIDS Soc (2017) 0.75
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration. S Afr Med J (2009) 2.97
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr (2010) 2.96
Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. Annu Rev Med (2010) 2.28
Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand. J Paediatr Child Health (2006) 1.93
Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass. J Bone Miner Res (2011) 1.64
Health care transition for youth living with HIV/AIDS. Pediatrics (2011) 1.62
Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc (2013) 1.59
Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav (2013) 1.51
Neurodevelopment in perinatally HIV-infected children: a concern for adolescence. J Int AIDS Soc (2013) 1.46
HIV status disclosure and retention in care in HIV-infected adolescents on antiretroviral therapy (ART) in West Africa. PLoS One (2012) 1.46
The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc (2013) 1.46
Antiretroviral treatment, management challenges and outcomes in perinatally HIV-infected adolescents. J Int AIDS Soc (2013) 1.39
Mental health treatment patterns in perinatally HIV-infected youth and controls. Pediatrics (2009) 1.34
Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons. J Dev Behav Pediatr (2012) 1.20
Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr (2012) 1.17
Metabolic complications and treatment of perinatally HIV-infected children and adolescents. J Int AIDS Soc (2013) 1.09
Disclosure of diagnosis by parents and caregivers to children infected with HIV: prevalence associated factors and perceived barriers in Addis Ababa, Ethiopia. AIDS Care (2012) 1.07
Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America. J Int AIDS Soc (2013) 0.98
Kidney disease in children and adolescents with perinatal HIV-1 infection. J Int AIDS Soc (2013) 0.97
Reproductive health decision-making in perinatally HIV-infected adolescents and young adults. Matern Child Health J (2013) 0.95
Bone mineral accretion and its relationship to growth, sexual maturation and body composition during childhood and adolescence. World Rev Nutr Diet (2013) 0.87
Bone health in children and adolescents with perinatal HIV infection. J Int AIDS Soc (2013) 0.87
Notification of HIV status disclosure and its related factors in HIV-infected adolescents in 2009 in the Aconda program (CePReF, CHU Yopougon) in Abidjan, Côte d'Ivoire, The PRADO-CI Study. J Int AIDS Soc (2013) 0.87
Metabolic complications associated with antiretroviral therapy in HIV-infected and HIV-exposed uninfected paediatric patients. Expert Opin Drug Saf (2010) 0.84
Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med (2008) 17.12
Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med (2010) 3.81
Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med (2011) 3.29
Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children. N Engl J Med (2012) 2.50
Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. BMJ (2006) 2.13
Tuberculosis-associated immune reconstitution inflammatory syndrome and unmasking of tuberculosis by antiretroviral therapy. Clin Chest Med (2009) 1.68
Early antiretroviral therapy improves neurodevelopmental outcomes in infants. AIDS (2012) 1.59
Clinical presentation and outcome of tuberculosis in human immunodeficiency virus infected children on anti-retroviral therapy. BMC Pediatr (2008) 1.49
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis (2010) 1.39
Protease inhibitor resistance in South African children with virologic failure. Pediatr Infect Dis J (2009) 1.37
Resistant Mycobacterium bovis Bacillus Calmette-Guérin disease: implications for management of Bacillus Calmette-Guérin Disease in human immunodeficiency virus-infected children. Pediatr Infect Dis J (2004) 1.36
Antiretroviral drugs for preventing mother-to-child transmission of HIV: a review of potential effects on HIV-exposed but uninfected children. J Acquir Immune Defic Syndr (2011) 1.26
The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis (2007) 1.19
Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr (2012) 1.17
Increased microbial translocation in ≤ 180 days old perinatally human immunodeficiency virus-positive infants as compared with human immunodeficiency virus-exposed uninfected infants of similar age. Pediatr Infect Dis J (2011) 1.11
High prevalence of lipoatrophy in pre-pubertal South African children on antiretroviral therapy: a cross-sectional study. BMC Pediatr (2012) 1.08
Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases. Pediatr Infect Dis J (2007) 1.08
A proposed comprehensive classification of tuberculosis disease severity in children. Pediatr Infect Dis J (2012) 1.04
Human metapneumovirus infection in hospital referred South African children. J Med Virol (2004) 1.03
Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2 years of life. Clin Vaccine Immunol (2012) 0.93
Adherence to isoniazid prophylaxis among HIV-infected children: a randomized controlled trial comparing two dosing schedules. BMC Med (2009) 0.93
Sulfamethoxazole enhances the antimycobacterial activity of rifampicin. J Antimicrob Chemother (2012) 0.92
Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens. PLoS Med (2008) 0.92
Ontogeny of Toll-like receptor mediated cytokine responses of South African infants throughout the first year of life. PLoS One (2012) 0.92
Effect of HIV-1 exposure and antiretroviral treatment strategies in HIV-infected children on immunogenicity of vaccines during infancy. AIDS (2014) 0.90
Making BCG vaccination programmes safer in the HIV era. Lancet (2008) 0.90
The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med (2014) 0.90
Immunogenicity following the first and second doses of 7-valent pneumococcal conjugate vaccine in HIV-infected and -uninfected infants. Vaccine (2012) 0.90
Bacterial disease and antimicrobial susceptibility patterns in HIV-infected, hospitalized children: a retrospective cohort study. PLoS One (2008) 0.90
It is time to consider third-line options in antiretroviral-experienced paediatric patients? J Int AIDS Soc (2011) 0.89
Predictors of virologic and clinical response to nevirapine versus lopinavir/ritonavir-based antiretroviral therapy in young children with and without prior nevirapine exposure for the prevention of mother-to-child HIV transmission. Pediatr Infect Dis J (2014) 0.88
Children with human immunodeficiency virus infection admitted to a paediatric intensive care unit in South Africa. J Trop Pediatr (2007) 0.88
Premasticating food for weaning African infants: a possible vehicle for transmission of HIV. Pediatrics (2011) 0.86
Surveillance of transmitted resistance to antiretroviral drug classes among young children in the Western Cape Province of South Africa. Pediatr Infect Dis J (2010) 0.86
The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Rev Vaccines (2014) 0.86
Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. S Afr Med J (2011) 0.85
Effect of in-utero HIV exposure and antiretroviral treatment strategies on measles susceptibility and immunogenicity of measles vaccine. AIDS (2013) 0.83
Bacteremia in human immunodeficiency virus-infected children in Cape Town, South Africa. Pediatr Infect Dis J (2011) 0.83
Nosocomial pneumonia in pediatric patients: practical problems and rational solutions. Paediatr Drugs (2002) 0.83
Maternal post-traumatic stress disorder, depression and alcohol dependence and child behaviour outcomes in mother-child dyads infected with HIV: a longitudinal study. BMJ Open (2013) 0.82
Optimizing the detection of recent tuberculosis infection in children in a high tuberculosis-HIV burden setting. Am J Respir Crit Care Med (2015) 0.82
The challenge of chronic lung disease in HIV-infected children and adolescents. J Int AIDS Soc (2013) 0.82
Renal manifestations in children co-infected with HIV and disseminated tuberculosis. Pediatr Nephrol (2010) 0.80
Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study. BMC Res Notes (2011) 0.80
Isoniazid preventive therapy in HIV-infected and -uninfected children (0 - 14 years). S Afr Med J (2013) 0.80
Estimation of intracellular concentration of stavudine triphosphate in HIV-infected children given a reduced dose of 0.5 milligrams per kilogram twice daily. Antimicrob Agents Chemother (2013) 0.80
Utility of clinical parameters to identify HIV infection in infants below ten weeks of age in South Africa: a prospective cohort study. BMC Pediatr (2011) 0.79
Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Ther Drug Monit (2012) 0.79
A retrospective study of cryptosporidial diarrhea in a region with high HIV prevalence. J Trop Pediatr (2010) 0.79
High Prevalence of Dyslipidemia and Insulin Resistance in HIV-infected Prepubertal African Children on Antiretroviral Therapy. Pediatr Infect Dis J (2016) 0.78
Clinical and immunological correlates of chest X-ray abnormalities in HIV-infected South African children with limited access to anti-retroviral therapy. Pediatr Pulmonol (2013) 0.78
Implementation and Operational Research: Implementation of the WHO 2011 Recommendations for Isoniazid Preventive Therapy (IPT) in Children Living With HIV/AIDS: A Ugandan Experience. J Acquir Immune Defic Syndr (2016) 0.77
Nevirapine concentrations in preterm and low birth weight HIV-exposed infants: implications for dosing recommendations. Pediatr Infect Dis J (2014) 0.77
Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa. J Trop Pediatr (2011) 0.77
Radiology services for children in HIV- and TB-endemic regions: scope for greater collaboration between radiologists and clinicians caring for children. Pediatr Radiol (2009) 0.77
Antiretroviral therapy in children with tuberculosis: progress toward defining the issues. J Infect Dis (2010) 0.77
Nitazoxanide for severe cryptosporidial diarrhea in human immunodeficiency virus infected children. Pediatr Infect Dis J (2008) 0.77
Biceps skin-fold thickness may detect and predict early lipoatrophy in HIV-infected children. Pediatr Infect Dis J (2013) 0.77
The Effect of Deworming on Tests of Tuberculosis Infection in Children With Recent Tuberculosis Exposure: A Randomized Controlled Trial. Pediatr Infect Dis J (2016) 0.76
Cytomorphological patterns of M. bovis BCG and M. tuberculosis on fine needle aspiration biopsies: does HIV make a difference? Diagn Cytopathol (2011) 0.76
A randomized controlled trial of intermittent compared with daily cotrimoxazole preventive therapy in HIV-infected children. AIDS (2010) 0.76
Trough lopinavir concentrations in preterm HIV-infected infants. Pediatr Infect Dis J (2012) 0.76
Spastic diplegia in children with HIV encephalopathy: first description of gait and physical status. Dev Med Child Neurol (2013) 0.75
Antiretroviral regimens containing a single protease inhibitor increase risk of virologic failure in young HIV-infected children. Pediatr Infect Dis J (2013) 0.75
Another milestone in minimizing risks to mothers exposed to single-dose nevirapine for prevention of vertical transmission of HIV-1 to infants: what next? Clin Infect Dis (2010) 0.75
A Prospective Cohort Study of Common Childhood Infections in South African HIV-exposed Uninfected and HIV-unexposed Infants. Pediatr Infect Dis J (2017) 0.75
Profile of Young South African Children Hospitalized With HIV: Cause for Concern. Pediatr Infect Dis J (2020) 0.75
Re: "It May Be Too Early to Try to Prove the Effect of Deworming on Tuberculin Reactivity". Pediatr Infect Dis J (2017) 0.75
Antiretroviral Treatment Initiated in the First Month of Life. Pediatr Infect Dis J (2016) 0.75
Complicated and protracted cryptococcal disease in HIV-infected children. Pediatr Infect Dis J (2015) 0.75
Late Onset HIV Encephalopathy in Children with Long-Standing Virologic Suppression Followed by Slow Spontaneous Recovery despite No Change in Antiretroviral Therapy -Four Case Reports. Pediatr Infect Dis J (2017) 0.75
Second- and Third-line Antiretroviral Therapy for Children and Adolescents: A Scoping Review. Pediatr Infect Dis J (2017) 0.75
Presumed cytomegalovirus retinitis in human immunodeficiency virus type I-infected South African children. Pediatr Infect Dis J (2011) 0.75
Pediatric and adolescent imported malaria in Cape Town. Pediatr Infect Dis J (2009) 0.75